Brain Health Therapies
Cutting-Edge Brain Health Therapies at Forum Health Denver
For over 20 years, our office has prioritized innovative brain health therapies. Dr. Grover served as the Co-Principal Investigator in a groundbreaking research study published in 2017, demonstrating the benefits of transcranial Near-Infrared Light Therapy (NILT) for Traumatic Brain Injury (TBI) in wounded warriors. View the article here.
In addition to his research, Dr. Grover is the author of Spiritual Genomics, a book that explores mindfulness-based strategies—such as sound healing, meditation, and nature immersion—designed to optimize gene expression for enhanced cognitive function.
- Mitochondrial-boosting therapies: NAD+ and methylene blue (oral or IV) to enhance cellular energy production.
- Intranasal peptides and/or stem cells to support neuroregeneration.
- Ketamine therapy is offered under the guidance of licensed clinicians as part of individualized care for mood and emotional well-being.
- Psilocybin microdosing guidance for cognitive enhancement and emotional resilience. (For patients that have self-initiated this therapy)
- Mindfulness-based techniques, including meditation, breathwork, and movement practices such as yoga, Tai Chi, and Qi Gong.
- Guidance for plant medicine retreats abroad for those seeking alternative healing experiences.
- Nutritional strategies tailored for optimal brain health, including targeted supplementation.
- Exercise recommendations to support cognitive function and neurogenesis.
- Advanced brain imaging referrals, including SPECT imaging, MRI, fMRI and QEEG brain mapping.
- Proactive sleep apnea screening and treatment, recognizing its critical role in cognitive function.
- Hormonal balance optimization, including sex hormones, thyroid, and growth hormone regulation.
Through this integrative and personalized approach, Dr. Grover, and his team continues to support individuals in enhancing brain function, resilience, and overall well-being. He is in the process of writing a book on Psychedelics and Brain Health, with planned publication in Summer of 2025.
